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Abstract: Although discrimination has been shown to adversely affect the health of
marginalized populations, there is a paucity of research on the health impacts of
discrimination experienced by illicit drug users. The purpose of this study was to
examine the association between interpersonal discrimination and the mental and
physical health of illicit drug users taking into account several potential confounding
factors. A sample of 1,008 active illicit substance users (defined as having used
cocaine, crack, or heroin in the previous 2 months) were recruited in three New York
City neighborhoods between August 2000 and January 2001 using street-outreach
techniques. Discrimination due to illicit drug use was the most common form of
interpersonal discrimination experienced and more than one-half the study participants
reported experiencing discrimination due to more than one attribute. Discrimination
was significantly associated with poor mental health (measured by the SF-36 mental
health score), depression (measured by the CES-D), and the number of self-reported
chronic physical health conditions. The presence of multiple stigmatizing character-
istics was associated with poorer mental and physical health. Discrimination may
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contribute to poor mental and physical health in this marginalized population,
potentially complicating the provision of substance abuse treatment.
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INTRODUCTION
Discrimination has been defined as the ‘‘process by which a member, or
members, of a socially defined group is, or are, treated differently because of
his/her/their membership of that group’’ (1). Discrimination exists at multiple
levels. Individual experiences of discrimination refer to discriminatory
interactions between individuals that can be directly perceived. These
experiences are believed to generate stress and alter physiological processes
that may adversely affect health (2). There are also structural and institutional
forms of discrimination such as segregation, which are believed to harm health
by limiting the socioeconomic opportunities, mobility, health care access and
the life chances of individuals who are being discriminated against (2).
Discriminatory treatment throughout society has been well documented
in the academic literature (3). Mounting evidence suggests that discrimina-
tion has a negative impact on mental and, to a lesser extent, physical health.
For example, discrimination due to one’s race has been shown to be
associated with elevated blood pressure in Blacks (4, 5), with poor global
ratings of physical health (2, 6, 7), with poor global ratings of mental health
(2, 8, 9), and with depression (10, 11). The adverse effects of discrimination
on health are not limited to race. Experiences of discrimination also have
been shown to adversely affect the health of other marginalized groups
including women (12), persons who are overweight (13), and persons of
bisexual and homosexual sexual orientation (14).
It also has been shown that people who experience discrimination due to
multiple attributes (e.g., race, gender, sexual orientation) may have poorer
health than those who experience discrimination due to one attribute (15, 16).
In one study, White gay men reported mainly antigay discrimination while
lesbian women reported both antigay and gender discrimination and Black,
gay women reported racial discrimination, antigay discrimination, and gender
discrimination (14). Another study found that lesbian and gay Blacks
reported higher rates of psychological distress than would be predicted based
on the sum of their risk from experiences of racial, gender, and sexual
orientation discrimination (17).
For two reasons persons who use illicit substances such as cocaine,
heroine, or crack may be particularly vulnerable to discrimination. First,
negative attitudes toward illicit substance users may be more pervasive than
negative attitudes toward other marginalized groups (18). A body of work has
documented the widespread stigma of illicit drug use (19, 20). For example,
the majority of Americans perceive cocaine users to have ‘‘no future,’’ to be
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‘‘losers,’’ to be ‘‘self-centered,’’ and to be ‘‘lazy;’’ they believe that drug use
and criminal activity are linked (21). As a result, substance users tend to be
poorly integrated into society and isolated from available services making
them particularly vulnerable to the health effects of discrimination. Second,
illicit drug users often possess multiple stigmatizing attributes (22). For
example, even though the rates of drug use are comparable across racial
groups, Blacks are more likely than Whites to be arrested, convicted, and
sentenced to prison due to drug related offences (23). Compared to adults
who do not use illicit drugs, adults who use illicit drugs are more likely to
have a serious mental illness and to be unemployed (24).
Despite illicit drug users’ potentially heightened vulnerability to
discrimination, we do not know of any peer-reviewed research that has
examined the health effects of discrimination on illicit drug users. In a recent
study, we reported that in a minority population of illicit substance users
discrimination due to drug use was the most common form of discrimination
experienced, and that discrimination due to drug use was reported as the type
of discrimination that had most impacted the lives of study participants (22).
In this follow-up study, we were interested in the association between
interpersonal forms of discrimination and the health of illicit drug users.
Specifically, we examine two research questions: 1) What is the relation of
experiences of interpersonal discrimination due to illicit drug use and the
mental and physical health of persons who use illicit drugs? 2) Are illicit drug
users who possess more than one stigmatizing attribute at heightened risk for
poor mental and physical health?
METHODS
Study Design and Sample
In this cross-sectional study, we recruited illicit drug users from Central
Harlem, East Harlem, and the South Bronx in New York City. These
neighborhoods were chosen because they share similar patterns of income,
education, crime, and have disproportionately high rates of smoking,
substance abuse, and HIV infection (25–27). Persons 18 years of age or
older who used cocaine, crack, or heroin in the previous two months were
eligible for inclusion in the study. Participants were recruited during the
period of August 2000 through January 2001 using a variety of street-
outreach techniques. Project outreach workers approached substance users on
the street, placed advertisements in service agencies, and handed out
pamphlets to interested persons. New participants also were recruited by
word of mouth from enrolled participants. These recruitment methods have
been previously shown to be particularly important when working with active
substance users, and probably represent the most effective documented
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method of recruitment for this group (28–30). The study was approved by the
Institutional Review Board of the New York Academy of Medicine.
Data Collection
Data was collected through structured, confidential, interviews conducted by
trained interviewers at a storefront research center in Central Harlem.
Participants first underwent a face-to-face screening interview to determine
eligibility. Once participants were determined to be eligible for the study,
trained interviewers explained the research protocol and obtained informed
consent. The 45-minute survey was administered in English or Spanish. All
participants were offered counseling and appropriate service referral as well
as $15 compensation for participating in the study.
Survey Measures
Dependent Variables
To assess perceived physical functioning and general mental health we used
two of the eight subscales included in 36-Item Short Form Health Survey
(SF-36): the physical functioning scale and the general mental health score.
The SF-36 developed for use in the Medical Outcomes Study, is a self-report
instrument that assesses current (in the last 4 weeks) perceived health status
and has been used in substance abusing populations (31). The physical
functioning scale is based on responses to 10 items, whereas the general
mental health score is based on responses to 5 items. Both are standardized
and range from 0–100. On each subscale, lower scores are associated with
poorer health; higher scores with better health. Depression in participants was
assessed using the Center for Epidemiologic Studies Depression (CES-D)
Scale, which is one of the most widely used self-report instruments to
measure current depressive symptomatology (32, 33). It is based on responses
to 20 items and ranges from 0–60. Lower scores are associated with less
depressive symptomatology whereas higher scores are associated with more
depressive symptomatology. We also asked participants if they had ever been
told by a health care provider if they had any of a list of health problems as an
additional list of mental health. A list of 12 health problems taken from the
Nutrition Examination Survey Epidemiologic Follow-up Study were read
(e.g., high blood pressure, cancer, diabetes) and participants responded yes or
no to whether they had or have each one (34, 35). They also were given the
option to volunteer if they had any other health problem. Responses were
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summed to create a scale measuring the number of chronic conditions for
each individual ranging from 0–11.
Independent Variables
The measure of discrimination used was modified from previous studies
(36, 37). Participants were asked, ‘‘Have you ever been prevented from doing
something, or been hassled or make to feel inferior because of any of the
following?’’ Participants were offered a list to choose from including age, race,
sex, sexual orientation, being poor, drug use, having been in jail or prison, or
other. Participants could select as many of these types of discrimination as were
applicable. We created a summary score of discrimination based on the number
of different types of discrimination experienced by participants. Participants
also were asked which type of discrimination had most impacted their life.
In order to assess the relationship between discrimination and health in
illicit drug users it is important to control for additional factors that may
confound or mediate this relationship. The age, sex, race (Black Non-
Hispanic, Hispanic/Latino, or Other), educational level, annual household
income before taxes, and marital status (single, married, other) of participants
were obtained. Participants were asked if they were homeless in the last
6 months and if they had ever been arrested or spent time in jail. Drug use in
the last 2 months was assessed. For example, participants were asked if they
used cocaine: never (coded as 0), once a month or less (coded as 1), 2–3 days
a month (coded as 2), about once a week (coded as 3), 2–3 days a week
(coded as 4), 4–6 days a week (coded as 5) or everyday (coded as 6) over the
past 2 months. The same scale was used to assess use of crack, heroin, or
injected illegal drugs. A summary variable to assess the frequency of drug use
across all types of drugs was created by summing responses to these
variables. This variable is important to control for because persons who use
illicit drugs less often may be less likely to experience discrimination
compared to persons who use illicit drugs more often and as a result, face a
lower cumulative burden from discrimination.
Participants’ social support was assessed using responses to 7 items
previously used in the Human Immunodeficiency Virus Epidemiology
Research Study (38). We asked if in the last 6 months was there someone
1. who would help take care of you if you were sick in bed for several weeks;
2. you could turn to if you needed help with small jobs around the house;
3. you could turn to if you needed to borrow several hundred dollars for a
medical emergency;
4. you could turn to if you needed advice to help you make a decision;
5. to talk to if you were upset, nervous, or depressed;
6. who you could turn to if you needed to borrow $10;
7. around to confide in or talk about yourself or your problems?
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For each variable those who answered probably or definitely yes were
coded as a 1 whereas those who answered probably or definitely not were
coded as a 0. Responses were summed to create an overall measure of
social support ranging from 0–7. The richness of the respondent’s social
network was assessed by asking participants how many relatives and friends
they have that they feel close to. Possible responses included none (coded
as 0), 1 (coded as 1), 2–4 (coded as 2), 5–9 (coded as 3), and 10 or more
(coded as 4).
Statistical Analysis
Two-tailed student t-tests were used to determine the association between
each type of discrimination and scores on each of the four self-assessed
health outcomes. Bivariate associations between each of the independent
variables and each of the four self-assessed health outcomes were assessed. In
separate multivariable regression models, we assessed the association
between each type of discrimination and the participants’ scores on each of
the four self-assessed health outcomes. We adjusted for age, education, race,
gender, income, education, social support, social network, and the frequency
of drug use in the models predicting the general mental health score and
depression. In the models predicting physical functioning and the number of
health problems we further adjusted for current number of cigarettes smoked
per day as well as for the participants’ general mental health (assessed from
the SF-36). All calculated p values were two-tailed, and 95% confidence
intervals were used to guide interpretation.
RESULTS
A total of 1,008 participants were recruited for this study. Selected
demographic characteristics of the study population are displayed in
Table 1. The majority of participants were male (63.9%) and single
(62.3%). The mean age of participants was 40.4 (SD=8.2). Nearly one-half of
the sample was Black (49.7%) and 41.7% were Hispanic. Approximately
one-half of the respondents (48.9%) did not graduate from high school. There
was a high prevalence of previous incarceration (91.2%), and 50% of the
participants had been homeless in the previous 6 months. Approximately one-
half (45.9%) of the participants had used intravenous drugs in the previous
2 months, and more than 60% had used cocaine (62.3%) and heroin (63.2%).
On a scale ranging from excellent to poor, most participants reported their
overall health status was moderate (good=31.6%; fair=48.9%). Mean scores
on the SF-36 scale measuring mental health and physical functioning were
M. Young et al.376











Age (years): mean (SD) 40.4 8.2




Years of education: n (%)
Less than high school 493 48.9
GED or high school graduate 301 29.9
Some college 178 17.7
College graduate 33 3.3
Annual household income/10,000: mean (SD) 0.79 0.86
Homeless (past 6 months): n (%) 503 50.00
Previously arrested: n (%) 917 91.2
Previously spent time in jail: n (%) 720 72.1
Drug use and treatment: n (%)




Intravenous use 458 45.9
Currently enrolled in drug treatment 555 55.3
Health





Mental health: mean (SD)
(0–100; 100 is good mental health)
58.4 21.7
Depression: mean (SD) (0–60; 60 high depression) 24.7 12.8
Physical functioning: mean (SD)
(0–100; 100 is good physical health)
73.3 29.6
# of chronic conditions: mean (SD) 2.12 1.70
aN may not add up to 1,008 due to missing values.
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58.4 and 73.3, respectively. The mean score on the CES-D scale was 24.7 and
the average number of chronic physical health problems was 2.12.
Table 2 shows the prevalence of each domain of discrimination reported
by participants. Overall, 82.7% of participants reported some form of
discrimination. More participants reported experiencing discrimination due to
drug use (75.3%) than any other category. Discrimination due to previous
incarceration was the second most frequently reported domain (40.3%),
followed by poverty (32.7%) and race (31.3%). Fewer participants reported
experiencing discrimination because of their gender (14.2%), and 10%
reported experiencing discrimination because of their sexual orientation.
Most participants (81.7%) reported experiencing discrimination because of
more than one attribute. In response to the question, which type of
discrimination most impacts your life 50.6% said discrimination due to drug
use, 10.6% said discrimination due to jail time, and 6.5% said discrimination
due to race/ethnicity.
Table 3 shows bivariate associations between each domain of dis-
crimination and the mental and physical outcomes. Mean health scores were
calculated for each type of discrimination comparing persons who
experienced discrimination versus those who did not. The following types
Table 2. Prevalence of different types of discrimination
(N=1,008)
N %
Ever experienced discrimination due to. . .
Drug use 759 75.3





Sexual orientation 101 10.0









aThis prevalence is calculated using the total sample. Of
the 720 people who ever spent time in jail, 368 (51.1%)
reported experiencing discrimination because of it.
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of discrimination were associated with poorer general mental health: drug-use
( p<.0001), poverty ( p=.0020), age ( p=.002), sex ( p=.05) and sexual
orientation ( p=.03). The following domains of discrimination were
associated with higher CES-D scores (more depressive symptomatology):
drug-use ( p=<.0001), poverty ( p=<.0001), age ( p=.005), sex ( p=.005),
and sexual orientation ( p=03). The following domains of discrimination














Mean p Mean p Mean p Mean p
Drug Use <0.001 <0.001 0.41 <0.001
Yes 56.8 25.8 72.9 2.23
No 63.3 21.5 74.7 1.81
Jail Time 0.57 0.31 0.31 0.21
Yes 58.9 25.1 74.5 2.20
No 58.1 24.4 72.5 2.07
Poverty 0.002 <0.001 0.37 0.004
Yes 55.4 27.0 72.1 2.4
No 59.9 23.6 73.9 2.0
Race 0.65 0.86 0.65 <0.001
Yes 58.9 24.8 73.0 2.0
No 58.2 24.6 73.4 2.4
Age 0.002 0.005 0.03 0.009
Yes 54.2 27.2 69.3 2.4
No 59.4 24.1 74.3 2.05
Sex 0.05 0.005 0.86 <0.001
Yes 55.0 27.7 72.9 2.4
No 59.0 24.2 73.4 1.9
Sexual
orientation
0.03 0.03 0.97 0.02
Yes 53.9 26.5 73.4 2.59
No 58.9 24.5 73.3 2.07
aBivariate associations were calculated using the student t-test.
bThe SF-36 mental health score is a continuous measure from 0–100 where 100 is
better mental health.
cThe CES-D depression score is a continuous measure form 0–60 where 60 is a
high level of depression.
dThe SF-36 physical functioning score is a continuous measure from 0–100 where
100 is better physical functioning.
eThe number of chronic conditions is a continuous measure, where a higher number
indicates the presence of more chronic conditions.



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































were associated with having more chronic health conditions: drug use
( p = .0007), poverty ( p = .004), race ( p = .0009), age ( p = .009), sex
( p=.0003), and sexual orientation ( p=.02). Only discrimination due to age
( p=. 03) was associated with poorer physical functioning.
Table 4 shows the results of separate multivariable models predicting
change in the mental and physical health scores for each type of
discrimination. A multivariable model also was estimated to assess the
potential impact of multiple types of discrimination. The following types of
discrimination were associated with a decrease in the general mental health
score: drug use, poverty, race, age, sex, and sexual orientation. The same
types of discrimination were associated with significant increases in the
depression score. All types of discrimination were associated with an increase
in the number of chronic physical health conditions. In contrast, none of the
types of discrimination were associated with the physical functioning score.
To illustrate the effects of the other factors adjusted for in these models,
in Table 5 we show the full model specification for the model that includes
the discrimination due to drug use variable. Discrimination due to drug use
was associated with poorer general mental health. In addition, having less
than a high school education, being female, using drugs more frequently, and
low levels of social support and network integration were associated with
poorer general mental health. These same variables were associated with
depression. Older participants, persons with less than a high school
education, females, and individuals in poorer mental health were more
likely to report poorer physical functioning. Older participants, participants
with less social support, who smoke more, who are in poorer mental health,
and who have experienced discrimination due to drug use reported having
more chronic physical health problems.
DISCUSSION
In this cross-sectional study we found that illicit drug users experience a high
burden of interpersonal discrimination; the majority of participants (81.7%)
reported having experienced at least one form of discrimination in their
lifetime. Discrimination due to drug use was the most prevalent form of
discrimination reported and was also the type of discrimination that most
affected the lives of study participants. The experience of discrimination due
to drug use was associated with poorer mental health, depression, and a count
of the number of chronic health problems among participants. The
association between poor mental health and discrimination was consistent
across different domains of discrimination, and appeared to be more robust
than the relation between self-reported discrimination and physical health.
To our knowledge, this is the first study to document the prevalence of
discrimination and its association to poor health in a population of illicit drug
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users. The majority of studies examining the health impacts of discrimination
have focused on African American adults living in the United States, but
increasing attention is now being given to other racial groups and to persons
with other stigmatized attributes (39, 40). Compared to other marginalized
groups, illicit drug users in this study reported a higher prevalence of
discrimination. For example, a study of Chinese Americans living in Los
Angeles found that approximately 26% of the respondents reported ex-
periencing discrimination because of their race (39), although the prevalence
of discrimination experiences has been reported to be significantly higher
among Blacks (3). In a national survey, homosexual and bisexual individuals
reported more discrimination than heterosexuals and 42% attributed this to
their sexual orientation (14). A study of persons with severe mental illness
found that 53% reported some experience with discrimination. The most
frequent sources of this discrimination were mental disability, race, sexual
orientation, and physical disability (40).
Illicit drug users may be particularly vulnerable to the many pathways
through which discrimination is believed to harm health. Interpersonal
discrimination, which we found to be highly prevalent in this population of
illicit drug users, may generate psychic distress that can lead to alterations in
physiological processes and adversely affect health (2). Research on other
stigmatized groups consistently has revealed a robust association between
interpersonal discrimination and poor mental health and, to a lesser extent,
discrimination and poor physical health (41). In addition to the stress
generated by experiences of discrimination, illicit drug users may also be
more exposed to other types of stress. For example, they may be more likely
to experience chronic day-to-day stress at work or at home related to their
drug use or major life traumatic events because they may be more likely to
live in communities characterized by high prevalence of violence. Additional
research is needed to discern the types of stress that are experienced by, and
that affect drug users and the factors that may mediate these stress reactions.
One such factor is social support. In this study we showed that
individuals with high social support and network integration are less likely to
have poor mental and physical health in multivariable models. Social
relations and social support may play a unique role in shaping the relation
between discrimination and poor health. For example, individuals with
stronger social networks and higher levels of perceived social support may be
better able to cope with major life stressors (42, 43). By contrast, those who
report lower levels of social support have been shown to be associated with
increased risk of dying prematurely from several causes of death (44, 45).
Resilience and vulnerability related to an individual’s social support may
affect her or his ability to cope with the stresses of discrimination and
ultimately may affect the relationship between discrimination and health.
Illicit drug users also may be more vulnerable than other stigmatized
groups to discrimination occurring at structural and institutional levels. For
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example, illicit drug users may be more likely to live in disenfranchised
neighborhoods where adverse conditions (e.g., inadequate medial care, high
rates of violence) may directly harm health. Studies of the health of illicit
drug users in the future should examine structural and institutional pathways
through which discrimination may harm health.
The finding that discrimination was not associated with physical
functioning but was associated with the other mental and physical health
outcome measured by this study was surprising. It is plausible that
discrimination harms mental health through the generation of stress, and
that negative emotional states such as depression have direct effects on
physiological processes or patterns of behavior that affect disease risk (46).
Thus, measures of mental health status and health behaviors then can be
viewed as an intermediary mechanism by which perceptions of discrimina-
tion ultimately may affect physical health. Physical functioning is not a
measure of health per se but rather can be viewed as a potential consequence
of poor mental and physical health with its own complex set of intermediary
mechanisms linking potential stressors to physical functioning. Our results
suggest that discrimination is not one of these factors.
An important gap in the peer-reviewed literature is that the cumulative
burden of discrimination is measured infrequently, potentially leading to
conservative estimates of the health effects of discrimination (47). We show
that persons who used drugs more frequently were in poorer mental health
(see Table 5), which may be a function of their having increased exposure to
discrimination (although there are other potential explanations for this
association). Studies of the health effects of discrimination are limited in that
they frequently focus on discrimination because of one stigmatized attribute
and thereby also may be underestimating the cumulative impact of
discrimination on health. We showed that illicit drug users, like other
marginalized populations (14, 17), experience discrimination because of
multiple attributes and that, in almost all cases, the discrimination due to
these other attributes adversely affected health. Furthermore, we showed that
the respondents who experience multiple forms of discrimination were at
higher risk for poor health. Longitudinal research that takes into account the
cumulative burden of discrimination for several stigmatized attributes is
needed to further explore the relationship between experiences of
discrimination and health in marginalized populations.
Limitations
There are several limitations to this study. First, and most importantly, given
that this was a cross-sectional study, we cannot definitively establish
a temporal relation between the hypothesized exposure (discrimination) and
outcome (poorer mental and physical health). Longitudinal work will
be needed to definitively establish a causal relation between experience of
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discrimination among drug users and their mental and physical health. Sec-
ond, we sampled illicit drug users from specific New York City neighbor-
hoods. While this allowed us to standardize, to some extent, structural factors
that also may be associated with physical and mental health of the illicit drug
users enrolled in this study, it also may limit the generalizability of the results
documented here. Third, we used self-reported measures of discrimination, as
well as self-reported measures of physical and mental health. It is possible that
individuals who reported experiencing discrimination also may be more likely
to inaccurately assess their health status. However, self-reported health has
been shown to be a valid predictor of morbidity and mortality (34) and
discrimination has been shown consistently to be a robust predictor of health
(27). Our study, using well-accepted measures of both discrimination and
health outcomes, shows that experiences of discrimination are associated with
health among illicit drug users. Additional limitations in our study include the
fact that we did not measure institutional levels of discrimination directly,
which may affect the relation we found. Also, we did not distinguish between
the frequency or the intensity of exposure of discrimination (e.g., day-to-day,
major lifetime exposure). Future studies in this area should attempt to take
these limitations into account.
Implications
Research on the consequences of stigma and discrimination in illicit drug users
is in its infancy. While this study showed an association between discrimination
because of drug use and the health of illicit drug users, research on other
stigmatized conditions such as HIV/AIDS and mental illness suggests that
there are likely to be many other consequences of stigma and discrimination for
drug users (48, 49). For example, discrimination due to drug use may shape
drug-use behavior, the availability of resources, access to social welfare
systems, and compliance with medications (50). Not unlike other marginalized
groups, illicit drug users may be especially vulnerable to health and other
consequences of discrimination because they frequently possess multiple
stigmatizing attributes such as homelessness or having spent time in jail or
prison. Future research should explore additional impacts of discrimination in
this population as well as the extent to which the presence of multiple stig-
matizing attributes exacerbates these associations. Public health interventions
aimed at improving the health of drug users should address discrimination as a
factor that may exacerbate the health consequences of illicit drug use.
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